Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The narcotic-MetroHealth Medical Center-postoperative pain regimen refers to a specific multimodal analgesic protocol evaluated in a randomized clinical trial (NCT03640247) conducted by MetroHealth Medical Center. This regimen was designed to manage pain following thyroidectomy and parathyroidectomy. It consists of a combination of non-opioid analgesics—specifically acetaminophen and ibuprofen—alternated for baseline pain control, supplemented with a prescription of 10 tablets of the opioid oxycodone (or hydrocodone/tramadol as alternatives for patients with allergies) for breakthrough pain. The regimen also includes non-pharmacological adjuncts such as ice packs and throat lozenges. The clinical study aimed to determine if this narcotic-containing regimen provided superior pain control compared to a non-narcotic regimen (acetaminophen and ibuprofen alone), ultimately finding no significant difference in pain scores and suggesting that many patients can be managed without opioids post-surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + ibuprofen + oxycodone (MetroHealth Medical Center).